INVESTIGATORS: STELLA MARIAHARTINGER, PhD; Victor G. Dávila-Román, MD, FACC, FASE; Elvin Geng, MD, MPH
Hypertension is the major contributor to the global burden of disease. Completion of this proposed cluster randomized trial will provide compelling, robust evidence on the effects of a multicomponent intervention aimed at reducing blood pressure levels in a high-risk, vulnerable population in Puno, Peru. These data are urgently needed to inform policies in low- and middle-income countries on the health gains that can be obtained by implementation strategies geared towards reducing reduce hypertension among vulnerable populations.
National Heart, Blood, and Lung Institute (5UG3HL152371-02)